Full Text View
Tabular View
No Study Results Posted
Related Studies
Genetic Epidemiology of Asthma in Costa Rica
This study has been completed.
Study NCT00021840   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: August 7, 2001   Last Updated: May 1, 2009   History of Changes

August 7, 2001
May 1, 2009
July 2001
February 2006   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00021840 on ClinicalTrials.gov Archive Site
 
 
 
Genetic Epidemiology of Asthma in Costa Rica
 

To identify genetic factors that influence the development of asthma in Hispanics.

BACKGROUND:

Asthma is a major public health problem in the United States, with particularly high prevalence rates among some Hispanic groups. Genetic linkage studies of this disease are of potentially great utility for the identification of those at risk, the search for new pharmaceutical treatments, and designing interventions to prevent development of asthma. Study power is greatly enhanced if a relatively isolated, homogeneous population with a significant prevalence of asthma can be identified. Such a population does not exist among Hispanics in the United States but is available in the Central Valley of Costa Rica.

DESIGN NARRATIVE:

The study concentrates on a genetically isolated Hispanic population with high asthma prevalence living in the Central Valley of Costa Rica. A genome screen will be conducted on large pedigrees multiplex for asthma and linkage analysis performed for seven intermediate phenotypes related to asthma including airway responsiveness; FEV1; bronchodilator responsiveness; skin test reactivity to common aeroallergens; serum total and allergen-specific IgE; and peripheral blood eosinophil count. A genome screen will also be conducted in the parent-child trios, and ancestral haplotypes will be reconstructed to identify regions influencing asthma-associated phenotypes. Within candidate regions demonstrating both linkage in extended pedigrees to asthma and/or asthma-related phenotypes and significant linkage disequilibrium within the unrelated asthmatic subjects, fine mapping will be performed by testing for genetic association to single nucleotide polymorphisms within positional candidate genes.

N/A
Observational
 
  • Asthma
  • Lung Diseases
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
February 2006
February 2006   (final data collection date for primary outcome measure)

No eligibility criteria

Both
 
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00021840
 
971
National Heart, Lung, and Blood Institute (NHLBI)
 
Investigator: Scott Weiss Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP